-
Mark L. Hart III
… of Tarpon Advisors, Inc. He earned a BA in Plan II Honors from The University of Texas at Austin in 1994. …
-
First Stem-cell-based Drug Approved in Canada
May 21, 2012
… Maryland. Prochymal is a treatment for children suffering from graft-versus-host disease following bone marrow …
-
Team Fox Young Professionals to team up with Helmut Lang
May 30, 2013
… label Helmut Lang for an exclusive evening of discounted shopping and cocktails at their Upper East Side location on Wednesday, June 12th from 6:30-8:30 p.m. Merchandise will be 10% off with an … Guests will enjoy drinks and hors d'ouvres while they shop! Please RSVP to Madison65@helmutlang.com if you plan to …
-
Michael A. Schwarzschild, MD, PhD
… to Parkinson’s disease (PD) and translates insights gained from preclinical laboratory models to clinical trials. His …
-
Paul Gotfredson, CPA
… CFO for Neuropore Therapies Inc. He graduated in accounting from the University of San Diego in 1989. He has 20 years of …
-
Thomas Hesterkamp, PhD
… pharmaceutical company Arpida. Dr. Hesterkamp graduated from the University of Marburg, Germany, as a human …